A61K 38 - Medicinal preparations containing peptides

Patents for A61K 38 - Medicinal preparations containing peptides (316,240)
11/2004
11/30/2004	US6825026 Nucleic acids; genetic engineering; culture product
11/30/2004	US6825008 Expressed ligand—vascular intercellular signalling molecule
11/30/2004	US6825007 Therapeutic and diagnostic methods and compositions based on Jagged/Notch proteins and nucleic acids
11/30/2004	US6825005 Methods and reagents to regulate apoptosis
11/30/2004	US6825003 Cyclic lipopeptide acylase
11/30/2004	US6824998 For determination in mammals via 1-anthraquinonylhydrazide with p-anialdehyde; drug screening; packaging; kits
11/30/2004	US6824994 Peptide ligands that mimic sensor kinases and inhibit response regulators
11/30/2004	US6824993 Nucleotide sequences coding polypeptide for use in the treatment, diagnosis and prevention of prostate cancer
11/30/2004	US6824991 Human bad polypeptides, encoding nucleic acids and methods of use
11/30/2004	US6824990 Methods of detecting and modulating oligomerization of G protein-coupled receptors
11/30/2004	US6824978 Regulation of endogenous gene expression in cells using zinc finger proteins
11/30/2004	US6824973 Nucleotide sequences coding polypeptides for use in the treatment of cell proliferative disorders
11/30/2004	US6824822 Residual solvent extraction method and microparticles produced thereby
11/30/2004	US6824783 Delaying the onset of aids in an hiv- 1 infected individual, comprising administering a peptide which inhibits membrane fusion-associated events, i.e. syncytia formation between hiv-1 infected cells and cells uninfected
11/30/2004	US6824779 Methods for inhibiting the interaction of B7-2 with its natural ligand
11/30/2004	US6824777 Flt4 (VEGFR-3) as a target for tumor imaging and anti-tumor therapy
11/30/2004	US6824775 88kDa tumorigenic growth factor and antagonists
11/30/2004	US6824773 TWEAK receptor
11/30/2004	US6824769 Compositions comprise alpha-interferon or a derivative thereof and an inosine monophosphate dehydrogenase inhibitor; hepatitis virus
11/30/2004	US6824768 Ribavirin-pegylated interferon alfa induction HCV combination therapy
11/30/2004	US6824767 Nuclelotide sequences coding polypeptide for use in the treatment of tumors, cachexia, septic shock, brain disorders, inflammation, arthritis and immunological defects
11/30/2004	US6824561 Implantable system with drug-eluting cells for on-demand local drug delivery
11/30/2004	CA2468118A1 Inhibition of gene expression by delivery of specially selected double stranded or other forms of small interfering rna precursors enabling the formation and function of small interfering rna in vivo and in vitro
11/30/2004	CA2319252C Circulating insulin-like growth factor-i and prostate cancer risk
11/30/2004	CA2267072C Reconstituted human anti-hm1.24 antibody
11/30/2004	CA2238439C Method for preparation of type ii collagen
11/30/2004	CA2173150C Novel peptide derivatives
11/30/2004	CA2144081C Protection against liver damage by hgf
11/30/2004	CA2089309C Novel pharmaceutical uses of bilobalide and derivatives thereof and pharmaceutical compositions adapted for such use
11/27/2004	CA2464379A1 Use of anti-glaucoma drugs to treat visual defects associated with the use of a gabaergic agent
11/25/2004	WO2004102195A1 Method for identifying tff2 regulating agents and agents identified using said method
11/25/2004	WO2004101826A2 Methods to identify compounds that modulate the autoinducer-2 dependent quorum sensing system in vibrio harveyi
11/25/2004	WO2004101789A1 Cardiotonic polypeptides
11/25/2004	WO2004101787A1 Inhibition of the expression of huntington gene
11/25/2004	WO2004101786A1 TRANSFORMING GROWTH FACTOR-β RESPONSE ELEMENT DECOYS AND METHODS BASED THEREON
11/25/2004	WO2004101747A2 Identification and use of gpr54 and its ligands for reproductive disorders and contraception
11/25/2004	WO2004101742A2 Protease inhibitors for coronaviruses and sars-cov and the use thereof
11/25/2004	WO2004101619A1 Rational design and synthesis of functional glycopeptide
11/25/2004	WO2004101617A1 Active variants of the il-18 binding protein and medical uses thereof
11/25/2004	WO2004101611A2 Peptides that bind to the erythropoietin receptor
11/25/2004	WO2004101608A2 Apo2l (trail) receptor binding peptides and uses thereof
11/25/2004	WO2004101607A2 Comparative ligand mapping from mhc class i positive cells
11/25/2004	WO2004101606A2 Novel peptides that bind to the erythropoietin receptor
11/25/2004	WO2004101605A1 Hepatitis c inhibiting compounds
11/25/2004	WO2004101603A1 Statine derivatives for the treatment of alzheimer's disease
11/25/2004	WO2004101602A2 Hepatitis c inhibitor peptide analogs
11/25/2004	WO2004101600A2 Novel poly(ethylene glycol) modified compounds and uses thereof
11/25/2004	WO2004101599A2 Antimicrobial peptide and methods of use thereof
11/25/2004	WO2004101597A2 Methods for the reduction of disulfide bonds
11/25/2004	WO2004101494A1 Calpain inhibitors
11/25/2004	WO2004101023A2 A method for altering insulin pharmacokinetics
11/25/2004	WO2004100997A2 Spacer moiety for poly(ethylene glycol) -modified peptides
11/25/2004	WO2004100990A1 Apoptosis inducer for cancer cell
11/25/2004	WO2004100988A1 Cardioprotective agent
11/25/2004	WO2004100987A2 Methods of using il-1 antagonists to treat neointimal hyperplasia
11/25/2004	WO2004100982A1 C1 inhibitor with short half-life for transient treatment
11/25/2004	WO2004100981A1 One or several enzyme-containing compounds, dietetic food products and drugs produced from said compounds and the use therefor for medical purposes
11/25/2004	WO2004100980A1 Interferon for treating or preventing a coronaviral infection
11/25/2004	WO2004100979A2 Liquid stabilized protein formulations in coated pharmaceutical containers
11/25/2004	WO2004100978A1 A method of modulating cellular transmigration and agents for use therein
11/25/2004	WO2004100977A1 Inhibition of tumor cell proliferation by foxm1b inhibitors
11/25/2004	WO2004100976A1 Klotho protein, anti-klotho protein antibody and use thereof
11/25/2004	WO2004100975A1 TREATMENT OF HAEMORRHAGIC SHOCK USING COMPLEMENT 5a RECEPTOR INHIBITORS
11/25/2004	WO2004100973A2 Pharmaceutical compositions of antithrombin iii for the treatment of retroviral diseases.
11/25/2004	WO2004100972A1 Preventive and/or remedy for diseases accompanied by tissue destruction
11/25/2004	WO2004100941A1 Pharmaceutical compositions
11/25/2004	WO2004100934A1 Insoluble globin injectable implant
11/25/2004	WO2004100899A2 Use of secretin in treatments of disorders associated with the amygdala
11/25/2004	WO2004100896A2 Anti-aging nutritional supplement
11/25/2004	WO2004100890A2 Rage g82s-related methods and compositions for treating inflammatory disorders
11/25/2004	WO2004100886A2 POLYNUCLEOTIDES AND POLYPEPTIDES ASSOCIATED WITH THE NF-kB PATHWAY
11/25/2004	WO2004100879A2 Method and composition for preventing or reducing edema, deep vein thrombosis and/or pulmonary embolism
11/25/2004	WO2004100878A2 Method of treatment of hemorrhagic disease using a factor viia/tissue factor inhibitor
11/25/2004	WO2004100872A2 Liquid aerosol formulations containing insulin and aerosol generating devices and methods for generating aerosolized insulin
11/25/2004	WO2004100870A2 Compositions and methods for wt1 specific immunotherapy
11/25/2004	WO2004100868A2 Method of treating transplant rejection
11/25/2004	WO2004100864A2 Treatment kit which assists with antibiotic therapy for intracellular infectious diseases
11/25/2004	WO2004100861A2 Pharmaceutical composition comprising lectin
11/25/2004	WO2004093898A3 Immunomodulatory product obtained from a bifidobacterium culture and compositions containing the same
11/25/2004	WO2004093662A3 Method for detecting prognosis of cancer
11/25/2004	WO2004087747A3 Citrullinated synthetic peptides and uses thereof
11/25/2004	WO2004081195A3 Use of secretin and secretin analogs to treat affective disorders
11/25/2004	WO2004074428A3 Treatment of metabolic disorders
11/25/2004	WO2004074315A3 Analogues of glp-1
11/25/2004	WO2004073616A3 Elastin digest compositions and methods utilizing same
11/25/2004	WO2004072095A3 Cyclized peptides as exotoxin antagonists
11/25/2004	WO2004071416B1 Novel inhibitors of formation of advanced glycation endproducts (ages)
11/25/2004	WO2004070057A3 Use of a novel polymorphism in the hsgk1 gene in the diagnosis of hypertonia and use of the sgk gene family in the diagnosis and therapy of the long qt syndrome
11/25/2004	WO2004069272A3 Adjuvant combination for use in the immunization of a mamal comprising il2 and il12
11/25/2004	WO2004067736A3 Custom-made meganuclease and use thereof
11/25/2004	WO2004060907A3 Compounds that bind p2y2 or p2y1 receptors
11/25/2004	WO2004056313A3 Prevention and treatment of cardiac arrhythmias
11/25/2004	WO2004053063A3 Molecular determinants of myeloma bone disease and uses thereof
11/25/2004	WO2004048601A3 Modulation of b7h expression
11/25/2004	WO2004037209A3 METHODS TO PREVENT TUMOR RECURRENCE BY BLOCKADE OF TGF-β
11/25/2004	WO2004034977A3 Orally administered peptides synergize statin activity
11/25/2004	WO2004030619A8 Protein s protects the nervous system from injury
11/25/2004	WO2004018624A3 Random transposon insertion in staphylococcus aureus and use thereof to identify essential genes
11/25/2004	WO2003103718A3 Intracellular delivery of biological effectors
11/25/2004	WO2003103589A3 Use of il-21 in cancer and other therapeutic applications

1 ... 1527 1528 1529 1530 1531 1532 1533 1534 1535 1536 1537 1538 1539 1540 1541 1542 1543 1544 1545 1546 1547 ... 3163